AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea
· Delayed Price · Currency is KRW
8,530.00
+350.00 (4.28%)
Oct 11, 2024, 9:00 AM KST
AptaBio Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 206,744 | 201,805 | 237,483 |
| Market Cap Growth | -5.73% | -15.02% | - |
| Enterprise Value | 174,143 | 152,862 | - |
| Last Close Price | 8360.00 | 9050.00 | 10650.00 |
| PE Ratio | - | -17.01 | -22.47 |
| PS Ratio | 90.71 | 623.11 | 4911.46 |
| PB Ratio | 3.72 | 3.29 | 4.53 |
| P/FCF Ratio | -13.17 | -13.07 | -30.16 |
| P/OCF Ratio | -14.20 | -14.32 | -34.76 |
| EV/Sales Ratio | 84.73 | 471.99 | - |
| EV/EBITDA Ratio | -11.05 | -9.34 | - |
| EV/EBIT Ratio | -10.71 | -9.04 | - |
| EV/FCF Ratio | -10.24 | -9.90 | - |
| Debt / Equity Ratio | 0.31 | 0.23 | 0.01 |
| Debt / FCF Ratio | -0.93 | -0.90 | -0.05 |
| Asset Turnover | - | 0.00 | - |
| Quick Ratio | 23.24 | 65.10 | 16.58 |
| Current Ratio | 26.59 | 70.27 | 19.63 |
| Return on Equity (ROE) | - | -21.21% | - |
| Return on Assets (ROA) | - | -14.22% | - |
| Return on Capital (ROIC) | - | -16.50% | - |
| Earnings Yield | -8.19% | -5.98% | -4.45% |
| FCF Yield | -8.22% | -7.65% | -3.32% |
| Buyback Yield / Dilution | -0.05% | -0.05% | - |
| Total Shareholder Return | -0.05% | -0.05% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.